Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Structural and Functional Characterization of a Multifunctional Alanine-Rich Peptide Analogue from Pleuronectes americanus

  • Ludovico Migliolo,

    Affiliation Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil

  • Osmar N. Silva,

    Affiliations Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil, Programa de Pós-Graduação em Genética e Biotecnologia, Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil

  • Paula A. Silva,

    Affiliations Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil, Departamento de Virologia-Instituto de Microbiologia Paulo Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil

  • Maysa P. Costa,

    Affiliation Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil

  • Carolina R. Costa,

    Affiliation Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil

  • Diego O. Nolasco,

    Affiliation Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil

  • João A. R. G. Barbosa,

    Affiliations Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil, Laboratório de Biofísica-Departamento de Biologia Celular, Universidade de Brasília, Brasília, Distrito Federal, Brazil

  • Maria R. R. Silva,

    Affiliation Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil

  • Marcelo P. Bemquerer,

    Affiliation Laboratório de Sîntese de Peptídeos, EMBRAPA Recursos Genéticos e Biotecnologia, Brasília, Brazil

  • Lidia M. P. Lima,

    Affiliation Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil

  • Maria T. V. Romanos,

    Affiliation Departamento de Virologia-Instituto de Microbiologia Paulo Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil

  • Sonia M. Freitas,

    Affiliation Laboratório de Biofísica-Departamento de Biologia Celular, Universidade de Brasília, Brasília, Distrito Federal, Brazil

  • Beatriz S. Magalhães,

    Affiliation Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil

  • Octavio L. Franco

    Affiliation Centro de Análises Proteômicas e Bioquímicas-Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Distrito Federal, Brazil

Structural and Functional Characterization of a Multifunctional Alanine-Rich Peptide Analogue from Pleuronectes americanus

  • Ludovico Migliolo, 
  • Osmar N. Silva, 
  • Paula A. Silva, 
  • Maysa P. Costa, 
  • Carolina R. Costa, 
  • Diego O. Nolasco, 
  • João A. R. G. Barbosa, 
  • Maria R. R. Silva, 
  • Marcelo P. Bemquerer, 
  • Lidia M. P. Lima


Recently, defense peptides that are able to act against several targets have been characterized. The present work focuses on structural and functional evaluation of the peptide analogue Pa-MAP, previously isolated as an antifreeze peptide from Pleuronectes americanus. Pa-MAP showed activities against different targets such as tumoral cells in culture (CACO-2, MCF-7 and HCT-116), bacteria (Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 25923), viruses (HSV-1 and HSV-2) and fungi (Candida parapsilosis ATCC 22019, Trichophyton mentagrophytes (28d&E) and T. rubrum (327)). This peptide did not show toxicity against mammalian cells such as erythrocytes, Vero and RAW 264.7 cells. Molecular mechanism of action was related to hydrophobic residues, since only the terminal amino group is charged at pH 7 as confirmed by potentiometric titration. In order to shed some light on its structure-function relations, in vitro and in silico assays were carried out using circular dichroism and molecular dynamics. Furthermore, Pa-MAP showed partial unfolding of the peptide changes in a wide pH (3 to 11) and temperature (25 to 95°C) ranges, although it might not reach complete unfolding at 95°C, suggesting a high conformational stability. This peptide also showed a conformational transition with a partial α-helical fold in water and a full α-helical core in SDS and TFE environments. These results were corroborated by spectral data measured at 222 nm and by 50 ns dynamic simulation. In conclusion, data reported here show that Pa-MAP is a potential candidate for drug design against pathogenic microorganisms due to its structural stability and wide activity against a range of targets.


Recently, advances in molecular biology have explained the complexity of life while retaining the simplicity of biology’s central dogma. Indeed, in the last few years many researchers have demonstrated that proteins and peptides possess a remarkable ability to adapt to the environment and develop a number of functions under specific conditions. In this context, protein and peptide promiscuity, in which multiple functions may be associated with a single structure in different environments, has been gaining attention in various research fields, including immunology, biochemistry and chemistry [1]. In fact, multiple functions seem to be an essential strategy of peptide evolution, facilitating the divergence of novel functions within accessible folds, and probably leading finally to the evolution of entirely new peptide functions.

In line with this view, the discovery of novel multifunctional peptides has been extremely important for understanding action mechanisms, behavior in different environmental parameters (pH and temperature, for example) and folding of several peptides. These bioactive molecules can be obtained from a wide variety of sources, including microorganisms, plants, amphibians, insects, mollusks and fish [2]. In Teleostei marine polar fish, antifreeze peptides (AFPs) are commonly secreted into the blood and various tissues, reaching a concentration of 10 to 40 mg.mL−1, depending on sub-zero temperature [3], [4]. The type I AFP family is commonly characterized from winter flounder (Pleuronectes americanus) by two peptides that present lower molecular masses, named HPLC-6 (4000 Da) and HPLC-8 (3300 Da) [5]. The secondary structure of peptides from this class consists of an alanine-rich α-helix composed of eleven amino acid residues with three imperfect motif repetitions (X10T, where X is any amino acid residue and T is threonine) [6]. A comparison between AFPs and antimicrobial peptides (AMPs) has revealed similar structural and physical-chemical properties, including hydrophobic ratio (45 to 55% hydrophobicity), polypeptide chain length (twenty to thirty amino acid residues), hydrophobic moment and a specific amino acid composition (mainly threonine, leucine, histidine, lysine, arginine, aspartic acid and alanine) [7]. These characteristics probably reflect the fact that many of these peptides may be capable of interacting with and disrupting target cell membranes [8]. Considering these shared characteristics, the key question is: Do these fish-sourced peptides have a single function? It seems that they do not, since the concept of peptides with multiple functions has been commonly observed in different organisms, representing savings in energy for organisms that express a single gene with multiple activities [1], [9].

Experiments in the 1990s suggested that both AFPs and AMPs might interact with biological membranes. However, the composition of cell membrane phospholipids and cholesterol is a determining factor in achieving cryopreservation or causing damage [10]. A decade later, Tomczak and Crowe proposed that the mechanisms of membrane stabilization and protection caused by type I AFP could be related and might be oriented by peptide insertion into the membrane [11]. Recently, studies demonstrated that stabilization of antifreeze peptides in the 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) model membrane using short segments of type I AFP could occur due to hydrophobic interactions of peptide with membrane core [12]. Additionally, the understanding of peptide-membrane interaction may allow the discovery and design of new biopharmaceuticals with high efficiency in controlling pathogenic microorganisms. The application of multiple active peptides (MAPs) in the control of high frequency infections caused by viruses, bacteria and fungi could open new frontiers in the search to identify alternative biocides whose novel mode of action may slow down the alarming trend toward resistance [13].

Multiple antifreeze peptide motifs from P. americanus (winter flounder) were obtained through NCBI database data mining. The antifreeze peptide was synthetically constructed with few differences of original peptide that was firstly expressed in bacterial heterologous system [14]. Here the peptide named Pa-MAP show two modifications, the absence of first amino acid residue methionine (initiation codon), unnecessary since we utilized chemical synthesis for peptide production and also showed a amidated C-termini, in order to improve peptide protection against medium degradation. This study uses chemical solid-phase synthesis with Fmoc strategy to produce a peptide with two 11-amino acid imperfect repeats. Pa-MAP was evaluated for its action toward multiple human-pathogenic microorganisms. Moreover, its secondary structure was also studied by circular dichroism (CD) and corroborated by further in silico comparative modeling and molecular dynamics (MD).

Experimental Section

Sequence Target for Studies of Multiple Activities

The primary sequence selected from a polar fish for multifunctional analysis consists of a characterized antifreeze peptide sequence from Pleuronectes americanus named HPLC-8. The synthesized peptide was based on the HPLC-8 antifreeze motif with two imperfect long repeats of eleven amino acid residues as described previously by Holmberg and coworkers [14]. The NCBI protein database [15] was used to acquire the antifreeze sequence (number AAC60714), BioEdit [16] was used to analyze the physical-chemical parameter of the template and ClustalW [17] was used for comparison of sequences.

Solid-phase Peptide Synthesis

The peptide was synthesized by the stepwise solid-phase method using the N-9-fluorenylmethyloxycarbonyl (Fmoc) strategy with a Rink amide resin (0.52 mmol.g−1) [18]. Side chain protecting groups were t-butyl for threonine and (triphenyl)methyl for histidine. Couplings were performed with 1,3-diisopropylcarbodiimide/1-hydroxybenzotriazole (DIC/HOBt) in N,N-dimethylformamide (DMF) for 60 to 120 min. Fmoc deprotections (15 min, twice) were conducted with 4-methylpiperidine:DMF solution (1∶4; by volume). Cleavage from the resin and final deprotection of side chains were performed with trifluoroacetic acid (TFA):water:1,2-ethanedithiol (EDT): triisopropylsilane (TIS), 94.0∶2.5∶2.5∶1.0, by volume, at room temperature for 90 min. After this, the crude product was precipitated with cold diisopropyl ether, collected by filtration and solubilized in 200 mL aqueous acetonitrile at 50% (by volume). The extracted peptide was twice freeze-dried for purification. Amino acid derivatives and other reagents for the solid-phase peptide synthesis were from Merck-NovaBiochem (Whitehouse Station, NJ) or from Peptides International (Louisville, KY) or from Sigma-Aldrich (St Louis. MO).

Peptide Purification

The crude peptide was solubilized in 0.1% trifluoroacetic acid (TFA) aqueous solution and filtered with a Millex filter 0.22 µm 25 mm (Millipore-Merck, Billerica, MA). The crude extract was submitted to semi-preparative reverse phase high-performance liquid chromatography (RP-HPLC), C18 NST, 5 µm, 250 mm×10 mm, using the following mobile phase conditions: H2O:ACN:TFA (95∶05:0.1, v:v:v) for 5 min, then a linear gradient to H2O:ACN:TFA (05∶95:0.1, v:v:v) for 60 min at a flow rate of 2.5 mL.min−1. The experiments were conducted at room temperature and monitored at 216 nm. Fractions were manually collected and lyophilized. The synthetic peptide concentrations for all in vitro experiments were determined by using the measurement of absorbance at 205, 215 and 225 nm, as described by Murphy and Kies [19].

Mass Spectrometry Analyses

Pa-MAP molecular mass was determined by using matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-ToF MS/MS) analysis on UltraFlex III, Bruker Daltonics, Billerica, MA. Purified peptide was dissolved in a minimum volume of water that was mixed with an α-cyano-4-hydroxycinnamic acid saturated matrix solution (1∶3, v:v), spotted onto a MALDI target plate and dried at room temperature for 5 min. The α-cyano-4-hydroxycinnamic acid matrix solution was prepared at 50 mM in H2O:ACN:TFA (50∶50:0.3, v:v:v). Peptide monoisotopic mass was obtained in the reflector mode with external calibration, using the Peptide Calibration Standard II for mass spectrometry (up to 4,000 Da mass range, Bruker Daltonics, Billerica, MA).

Potentiometric Titration

Aiming to identify the contribution of His1 amino acid residue, a potentiometric titration was realized according Crouch and coworkers [20]. This experiment demonstrated that the His1 was not protonated and therefore did not contributed with positive charge (Figure S1). The potentiometric titration curve for Pa-MAP was constructed using a DM –21 (Digimed, São Paulo, Brazil) pH meter coupled to a glass electrode combined with a thermo-compensating apparatus. A solution containing 5 mL of synthetic peptide in the concentration of 0.27 mM was solubilized in distilled water and acidified with a solution of hydrochloric acid, 1 mM until pH 3. Subsequently, the sample was titrated with the increasing volumes of 1 mM sodium hydroxide, until pH 9. Obtained pH values were registered as function of volume of added KOH.

Hemolytic Assays

The hemolytic activity of Pa-MAP was determined by using fresh human erythrocytes from healthy donors. Human heparine-blood was obtained from the Hospital of the Catholic University of Brasilia cell collection and stored at 4°C. Collection was obtained with written informed consent. Blood was centrifuged and the erythrocytes were washed three times with 50 mM phosphate buffer, pH 7.4. The peptide solution was added to the erythrocyte suspension (1%, by volume), at a final concentration ranging from 2 to 115 µM in a final volume of 100 µL. Samples were incubated at room temperature for 60 min. Hemoglobin release was monitored by measuring the supernatant absorbance at 540 nm. Zero hemolysis control (blank) was determined with erythrocytes suspended in the presence of 50 mM phosphate buffer, pH 7.4, and for positive control (100% of erythrocyte lyses); an aqueous solution of 1% (by volume) triton X-100 dissolved in distilled water was used instead of the peptide solution. This study was approved by the Animal Use Committee at the Institute of Biological Sciences, University of Brasilia. The hemolytic assays were performed in triplicate.

Cytotoxicity Assay

In order to determine the maximum non-toxic concentrations (MNTC) of the peptide Pa-MAP, several concentrations of peptide (200, 100, 50, 25, 12.5, 6.25 and 3.15 µg.mL−1) were assayed with confluent RAW 264.7 (mouse leukemic monocyte macrophage) cell line and incubated at 37°C in a 5% CO2 atmosphere for 48 h. After incubation, the cells were examined using an inverted optical microscope (Leitz) aiming to evaluate morphological alterations. Cellular viability was further evaluated by the neutral red dye-uptake method [21]. Cells were incubated in the presence of 0.01% (by weight) neutral red solution for 3 h at 37°C in a 5% CO2 atmosphere. Then the medium was removed and the cells were fixed with 4% formalin in phosphate-buffered saline, pH 7.2. The dye, incorporated by the viable cells, was eluted by using a mixture of methanol:acetic acid:water (50∶1:49, v:v:v), and the dye uptake was determined by measuring the absorbance at 490 nm in an automatic spectrophotometer (ELx800 TM-Bio-TeK Instruments, Inc.). The 50% cytotoxic concentration (CC50) was defined as the concentration that caused 50% reduction in dye uptake. The cytotoxic assays were performed in triplicate.

Assays for Cancer Cells in Culture

CACO-2 (heterogeneous human epithelial colorectal adenocarcinoma), MCF-7 (human breast cancer) and HCT-116 (human colorectal carcinoma) cells were acquired from the Cell Bank in Rio de Janeiro (CR108). The cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM Gibco), supplemented with 10% fetal serum bovine, penicillin (100 U.mL−1) and streptomycin (100 µg.mL−1), and maintained at 37°C in 5% of CO2 atmosphere (Invitrogen, Burlington, ON, Canada). Evaluation of the peptide against the tumor cells described above was assayed in two-fold dilutions (from 512 to 4 µg.mL−1). An MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) cytotoxicity test was used at 1 mg.mL- 1 to evaluate the cell viability after cells had been incubated with samples for periods of 24, 48 and 72 h. The ED50 values were calculated as the amount of Pa-MAP required to produce an inhibitory effect on the development in half of the population of cancer cells cultured in vitro. The cell culture assays were performed in triplicate.

Antifungal Tests

The minimum inhibitory concentrations (MICs) of Pa-MAP were determined by using the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) M27-S3 [22] with Roswell Park Memorial Institute (RPMI) 1640 medium. Stock solutions of peptide were dissolved in RPMI 1640 medium. The final concentrations ranged from 0.25 to 264 µg.mL−1. Briefly, a standard inoculum of clinically isolated (28d&E) Candida parapsilosis ATCC 22019, Trichophyton mentagrophytes var. mentagrophytes and clinically isolated (327) T. rubrum was initially produced. The cell density was adjusted by turbidity measurements (at 530 nm wavelength) to yield a fungal stock of 1 × 106 cfu per mL. Further dilutions were made with RPMI 1640 medium, resulting in a final inoculum of approximately 0.5 × 103 to 2.5 × 103 cells.mL−1. Next, 100 µL of the fungal suspension was incubated at 35°C and 100 µL of the Pa-MAP was placed in the wells of the microdilution tray. End points were visually read after 48 h for C. parapsilosis and 96 h for T. mentagrophytes var. mentagrophytes and T. rubrum. The MIC of Pa-MAP was considered as the lowest concentration that caused a complete growth inhibition (100%) when compared to control tube growth. Each antifungal test was carried out in triplicate.

Antibacterial Tests

Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 25923 were used for antimicrobial assays. The bacterial species were cultured in 1.0 mL LB broth for 2 h, at 37°C in accordance with guidelines from the CLSI, 2009. The synthetic peptide was incubated with 5×106 CFU.mL−1 for each bacterial species for 4 h, at 37°C. The negative and positive assay controls were bacteria in LB medium and in several dilutions of chloramphenicol, respectively. Bacterial growth was measured at 595 nm, every hour within the period of incubation, carried out according to protocols described by the National Committee for Clinical Laboratory Standards (NCLS) guidelines. All antibacterial experiments were carried out in triplicate. In addition, to determine the MIC, the peptide Pa-MAP was serially diluted from 256 to 2 µg.mL−1 in LB medium. The MIC was determined as the lowest concentration that caused complete growth inhibition (100%) in comparison to the negative control. In each well of a 96-well polypropylene plate, 100 µL of each dilution (medium + peptide) and 10 µL of cell suspension of bacteria were added (approximately 5×106 CFU of bacteria). The plates were incubated for 12 h at 37°C. During this period the absorbance was measured in a plate reader (Bio-Rad 680 Microplate Reader) at 595 nm every 30 min.

Cells and Viruses

Vero cells (African green monkey kidney cells) were grown in Eagle’s minimum essential medium (Eagle MEM) supplemented with 10% (by volume) fetal bovine serum, L-glutamine (0.03 mg.mL−1), garamycin (50 µg.mL−1), amphotericin B (2.5 mg.mL−1), NaHCO3 (0.25%) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, HEPES (10 mM). Cell cultures were prepared in 96-well microtiter plates (Falcon Plastics, Oxnard, CA, USA) and incubated at 37°C in a 5% CO2 atmosphere. HSV-1 was isolated from a typical lip lesion and HSV-2 from a typical genital lesion in the Virology Department of the Universidade Federal do Rio de Janeiro (UFRJ), Brazil. Viruses were typed by polymerase chain reaction (PCR) using specific primers for identification [23].

Antiviral Activity Assay

The antiviral activity of peptide Pa-MAP was evaluated by titer reduction. The virus titers were calculated using the statistical method and expressed as 50% tissue culture infective dose (TCID50) per mL [24]. Vero cell monolayers were treated with the peptide from 256 to 2 µg.mL−1 at the MNTC and 100 TCID50.mL−1 of HSV-1 or HSV-2 suspensions were added to treated and untreated cell cultures and incubated at 37°C for 48 h in a 5% CO2 atmosphere. After incubation, the supernatant was collected and virus titers in treated and untreated cells were determined. The antiviral activity was expressed as the percentage inhibition (PI) using antilogarithmic TCID50 values as follows: PI = [1 - (antilogarithmic test value/antilogarithmic control value)]×100. Test values consist of the number of viral particles produced in the presence of Pa-MAP and control value is the number of viral particle in the negative control without Pa-MAP. This formula was utilized to determine the viral inhibition percentage in according with Simões and coworkers [25]. The dose-response curve was established starting from the MNTC, and the 50% effective dose (ED50) was defined as the dose required to achieve 50% protection against virus-induced cytopathic effects [26]. The selectivity index (SI) was determined as the ratio of CC50 to ED50, and 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one or Acyclovir (Sigma Chemical Company, St Louis) was used as standard compound. Each antiviral assay was performed in triplicate.

Circular Dichroism Spectroscopy

Circular dichroism (CD) measurements were carried out on a JASCO J-815 spectropolarimeter (Easton, MD), equipped with a Peltier-type temperature controller, and a thermostable cell holder, interfaced with a thermostatic bath. Spectra were recorded in 0.1 cm path length quartz cells at a peptide concentration range of 0.05−0.5 mg.mL−1 in 2 mM Na-acetate buffer at pH 3.0, 2 mM Na-acetate buffer at pH 4.0, 2 mM Na-acetate buffer at pH 5.5, deionized water (Milli-Q), 2 mM Tris-HCl buffer at pH 7.0, 2 mM ammonium bicarbonate buffer at pH 8.5, 2 mM glycine-NaOH buffer at pH 10.0 and 2 mM glycine-NaOH buffer at pH 11.0. Four consecutive scans were accumulated and the average spectra stored. Thermal denaturation experiments were performed by increasing the temperature from 25 to 95°C, allowing temperature equilibration for 5 min before recording each spectrum. Pa-MAP analysis in the presence of sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) were performed in the same quartz cell with a 0.1 cm path length at 20°C. The spectra were recorded between 190 and 260 nm at a scan speed of 50 nm.min−1 and six scans were performed per sample. The spectra were recorded in three average environments: distilled water, 28 mM SDS micelles, and 50% (by volume) TFE in water. The observed ellipticity was converted into the mean residue ellipticity [θ] based on a mean molecular mass per residue of 115 Da. The data were corrected for the baseline contribution of the buffer and the observed ellipticities at 222 nm were recorded. The α-helical content of the various peptides was calculated from mean residual ellipticity at 222 nm ([θ]222) using the following equation: fH = [θ]222/[−40,000(1−2.5/n)], where fH and n represent the α-helical content and the number of peptide bonds, respectively [27].

In Silico Analyses and Molecular Modeling

The three-dimensional model for Pa-MAP was constructed based on the structure 1jb5 of the PDB, which presented 62% of identity between the primary sequences. Fifty theoretical three-dimensional peptide structures were constructed by Modeller v.9.8 [28] using the template. The final model was chosen as the best evaluated one using PROSA II [29] to analyze packing and solvent exposure characteristics and PROCHECK for additional analysis of stereochemical quality. In addition, RMSD value was calculated by overlapping the Cα traces and backbones onto the template structure with the 3DSS program aiming to identify and validate the best generated model. A small RMSD value reflects in a model with lower energy and consequently an enhanced structural stability [30]. The peptide structures were visualized and analyzed on Delano Scientific’s PYMOL - [31]. The electrostatic surface was calculated with the ABPS tool [32]. The grand average of hydropathicity, known as GRAVY, was calculated using ProtParam software [33].

Molecular Dynamics Simulation

The molecular dynamics simulations for the Pa-MAP model were carried out in two steps. The first step took place in water and the second one in TFE at 25 and 50% (by volume), similar to the in vitro analysis. The forcefield utilized was GROMOS96 43A1 and analyses were performed using the computational package GROMACS v.4. [34]. The dynamics had the best tridimensional model of Pa-MAP as initial structure, which was immersed in 7,897 water molecules in a cube box with sides measuring 6.22 nm. Sodium ions were also inserted to neutralize the charge of the system. A second step for TFE simulation at 50% was carried out with 1,892 and 2,023 water molecules and 459 and 354 TFE molecules in a cube box with sides measuring 4.78 nm for 25 and 50% of TFE, respectively. The Pa-MAP C-terminal was modified with an amide group for both steps [35]. Geometry of water and water/TFE 25 and 50% molecules was constrained using the SETTLE algorithm [36]. All atom bond lengths were linked by the LINCS algorithm [37]. Electrostatic corrections were made by algorithm Particle Mesh Ewald (PME) with a radius cut-off of 1.4 nm in order to minimize the computational simulation time. The same radius cut off was also used for van der Waals interactions. The list of neighbors of each atom was updated every 10 simulation steps of 2 fs each. A conjugate gradient (2 ns) and the steepest descent algorithms (2 ns) were implemented for energy minimization. After that, the system underwent a normalization of pressure and temperature, using the integrator stochastic dynamics (SD), 2 ns each. The system with minimized energy and balanced temperature and pressure was carried out using a step of position restraint, using the integrator Molecular Dynamics (MD), for 2 ns. The simulations were carried out at 20°C in silico, aiming to understand the structural conformation of the peptide in the presence of different environments. The total time of Pa-MAP simulation was 50 ns. The values obtained for radius of gyration, root mean square deviation and accessibility area represented the peptide flexibility. These values were obtained with linear regression are delta modules, encountered between the beginning and final simulation. This procedure was performed in order to shed some light over peptide stability. The linear regressions observed for the peptide in water were: y = 1.0927−6.9214e−06 * x; y = 0.52406+1.215e−05 * x and y = 15.195−4.1696e−05 * x for Rg, RMSD and Area. On the other hand, in TFE, the linear regressions observed were: y = 0.42061+2.0657e−07 * x; y = 1.2387 - 8.8112e−09 * x and y = 15.956 - 4.951e−07 * x for Rg, RMSD and Area, respectively.


Design, Syntheses and Purification of Pa-MAP

Pa-MAP was synthesized following the design for two 11-residue repeating segments from HPLC-8, with the following sequence: H-His-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Ser-Met-Ala-NH2. Pa-MAP was purified by semi-preparative reversed-phase chromatography with linear acetonitrile gradient of 5 to 95% ACN over water, with 0.1% TFA (Figure 1A). The chromatographic profile shows a major product being eluted with 48% of acetonitrile with minor contaminants with a retention time of 33.8 min. MALDI-ToF evaluation showed an ion with 2212.4 m/z, corresponding to the calculated value for the peptide sequence, with above 95% of purity for the isolated product (Figure 1B). Furthermore, K+ and Na+ adducts were also observed. All further bioassays were performed using this purified fraction, now named Pa-MAP.

Figure 1. Purification profile of Pa-MAP synthetic peptide.

(A) Reversed-phase chromatography C18 NST, 5 µm, 250 mm×10 mm column. Mobile phase conditions: H2O:ACN:TFA (95∶05:0.1, v:v:v) for 5 min, than a linear gradient to H2O:ACN:TFA (05∶95:0.1, v:v:v) in 60 min at a flow rate of 2.5 mL.min−1 and detection at 216 nm. Arrow indicate the main fraction containing Pa-MAP with retention time of 33.8 min. (B) MALDI Mass spectrometry analysis of Pa-MAP; monoisotopic mass [M+H+] = 2212.37. Inner squares represent the Na+ and K+ ion adducts.

Antibacterial Tests

The microdilution assays were performed in order to determine the ability of the Pa-MAP to reduce bacterial growth. Pa-MAP was efficient in controlling E. coli growth, presenting a MIC of 30 µM. On the other hand, for S. aureus, Pa-MAP only presented activity at higher concentrations, showing a MIC greater than 115 µM (Table 1).

Table 1. Toxicity and minimum inhibitory concentrations (MIC) of Pa-MAP against mammalian cells, tumor cells, fungi (yeast and mycelium), Gram-positive and -negative bacteria and viruses.

Antiviral Tests

By using Vero cells, the MNTC was determined as 90 µM for Pa-MAP. The activity of the peptide against HSV-1 and HSV-2 was tested through peptide titration until reaching non-cytotoxic concentration (MNTC). Pa-MAP caused 82% of HSV-1 inhibition at a concentration of 45 µM and 90% of HSV-2 at 23 µM. Moreover, 94 and 97% of inhibition for both HSV-1 and HSV-2 were observed at 90 µM (Table 1).

Antifungal Tests

The broth microdilution assay was performed in order to determine the ability of Pa-MAP to inhibit the development of mycellar fungi T. mentagrophytes and T. rubrum as well as the yeast C. parapsilosis. Growth inhibition for both T. mentagrophytes and T. rubrum was observed and the peptide presents a MIC of 115 µM. On the other hand, C. parapsilosis incubated with Pa-MAP demonstrated a MIC higher than 115 µM (Table 1), showing lower effects of Pa-MAP toward the yeast here evaluated.

Cytotoxic Studies for Tumoral Cells

The effects of Pa-MAP against tumor cells in culture were evaluated by using three cell lines: Caco-2 (human epithelial colorectal adenocarcinoma cells), HCT-116 (human colorectal carcinoma cell lines) and MCF-7 (human breast cancer cell). Pa-MAP showed activity against all tumor cells, reaching at 63, 31 and 55% inhibition for Caco-2, HCT-116 and MCF-7, respectively; at a concentration of 115 µM. ED50 was calculated for Caco-2 and MCF-7, reaching 58 and 110 µM respectively.

Cytotoxicity Studies

In order to investigate the hemolytic effects of Pa-MAP, red blood cells (RBCs) were incubated in phosphate-buffered saline, 50 mM, pH 7.4 (negative control), Triton X-100 (positive control) and also with several peptide dilutions (16, 32, 64, 128 and 256 µg.mL−1). Pa-MAP did not show any hemolytic effect (Table 1). In addition, no effects were seen of Pa-MAP toward the RAW 264.7 (mouse leukemic monocyte macrophage) cell line, which was observed to be viable in maximum peptide concentration assayed.

Circular Dichroism Analysis of Pa-MAP

The secondary structure of Pa-MAP was investigated using CD spectroscopy in water, SDS 7 and 28 mM, and TFE 50% solutions. CD spectrum in water (pH ∼7.0) showed the presence of a broad negative band around 216−218 nm and positive band ∼198 nm characteristic of the β-sheet structure (Figure 2A). This conformation was observed at several peptide concentrations, starting at 0.05 and progressing to 0.5 mg.mL−1 (data not shown). Otherwise, in SDS 28 mM (anionic micelle) the CD spectrum is arrested up to single minimum at ∼218, with a turning point at ∼208 nm, suggesting the presence of both β-sheet and α-helix structures. In the presence of TFE 50% the CD spectrum shape indicated that peptides adopt a defined α-helix secondary structure, marked by two minima around 208 and 222 nm, the positive band at 190 nm and molar ellipticity around zero at 200 nm. In addition, the helical contents were around 55% in aqueous TFE (at 50% by volume) and reached 60% at two different concentrations of SDS (Table 2).

Figure 2. Conformational changes of Pa-MAP evaluated by Far-UV circular dichroism in water, TFE and SDS environments.

(A) Pa-MAP CD spectra in water (dotted line), 28 mM SDS (dotted and dashed line) and 50% (by volume) TFE (continuous line). (B) Thermal and pH denaturation profiles of Pa-MAP. The symbols represent ▴ pH 3.0; ♦ pH 7.0; • pH 8.5 and ▪ pH 11.0. (C) Conformational hydrophobic effect of acetonitrile (v:v) on Pa-MAP. Molar ellipticity was monitored at 222 nm.

Table 2. Secondary structure content of Pa-MAP using the method described by Morrisett and coworkers 1973.

Thermal stability of the synthetic peptide was also evaluated in water, 2 mM Na-acetate buffer at pH 3.0, 2 mM ammonium bicarbonate buffer at 8.5 and 2 mM glycine-NaOH buffer at 11.0. The thermal unfolding curves in water, at pH 3.0 and 8.5, showed that the secondary structure of the peptide was preserved at temperatures ranging from 25 to 95°C (Figure 2B). In contrast, at pH 11.0 and 65°C a significant conformational loss, reaching approximately 45% of reduction, was observed (Figure 2B). In addition, the effect of acetonitrile was investigated in order to determine if hydrophobic interactions contributed to Pa-MAP stability. Aqueous acetonitrile solutions did not disturb the secondary structure up to 40% (by volume) (Figure 2C). However, a significant conformational change in the peptide was observed at 50% and a total loss of the secondary structure at 60%, with a consequent higher decrease in the dichroic signal.

Molecular Modeling of Pa-MAP

The primary sequence of HPLC-6 hydrophobic antifreeze peptide from P. americanus showed 62% of identity with Pa-MAP (Figure 3A) and its NMR tridimensional structure (pdb 1j5b) was used as template for molecular modeling [38]. The Pa-MAP model shows α-helical conformation (Figure 3B); this has also been observed in data obtained through prediction servers, such as PredictProtein and SOPMA, which presented 92 and 88% of the amino acid residues favoring this conformation [39], [40]. The Procheck summary of Pa-MAP showed that 95.8% of amino acid residues are located in the most favorable regions, and only 4.2% are in the region allowed for helix formation. Structural differences between the template structures and predicted three-dimensional structure of the peptide model were calculated by superimposing Cα traces and backbone atoms onto the template structures. The RMSD values between the experimental and theoretical models were 0.5 Å. The RMSD value and low variability among the structural templates and the model structure reflect conservation in most regions and emphasize a similar folding pattern throughout this peptide.

Figure 3. Theoretical tridimensional structure of Pa-MAP.

(A) Multiple alignment of Pa-MAP and the template (1jb5) used for tridimensional model construction. The black helix at the top of alignment represents the template secondary structure. (B) Tridimensional model of Pa-MAP constructed by Modeller 9.v.8 with the electrostatic surface calculated with APBS. Blue surfaces represent basic charges (the amino terminus) and red surfaces represent the acidic ones. Amino acid residues possibly involved in the interaction with multiple membrane-targets were labeled and highlighted.

Molecular Dynamics of Pa-MAP

In addition, in silico studies of Pa-MAP conformational dynamics in water and TFE solution were carried out. Figure 4 presents an overall view of the dynamic simulation for 50 ns with different snapshots of 5 ns runs conducted in water (A) and in the presence of TFE (B). In the simulation with water (Figure 4A) it was evident that the Pa-MAP underwent conformational modification after 30 ns of the run and the long helix was partially unfolded. Otherwise, in the simulation with TFE (Figure 4B) no modification was observed, and the peptide remained in α-helical conformation during the entire simulation. The α-helix stability observed in MD simulations is in agreement with the CD signal measured. The dynamic simulation was used to analyze some physical-chemical parameters, such as the radius of gyration (Rg), root mean square deviation (RMSD) and accessibility area for solvent (Area) for 50 ns, in two environments (water and TFE solution). These parameters were used to furnish data for the different conformations adopted in two different environments. The modifications observed in Rgs for Pa-MAP in water and TFE were 0.34 and 0 nm respectively; and this might be clearly observed after 30 ns of simulation in water indicated by a sloping negative line (Figure 5A). Nevertheless, in the TFE environment, no modification was observed during the simulation (Figure 5D). The change on RMSD values for the initial (0 ns) and final model (50 ns) for both simulation analyses were 0.6 and 0 nm, respectively (Figures 5B and 5E). The results demonstrated only a few modifications after 50 ns of simulation for this peptide and demonstrated that in water and TFE at 20°C, Pa-MAP kept the α-helix content at 42 and 90%, respectively (Figures 4A and 4B). The solvent accessible area presented variation values of 2.1 and 0 nm2, which are represented by a sloping negative line (Figures 5C and 5F). Data provided by CD demonstrated that Pa-MAP presented a partial α-helical structure, which was dynamically most favorable after 35 ns of dynamic simulation.

Figure 4. Molecular dynamics evaluation of Pa-MAP.

Structural snapshots along the 50 ns MD trajectory of Pa-MAP in water (light blue) (A) and TFE at 50% by volume solution (dark blue) (B) during the run. Structures are represented as cartoon and further visualized with PyMol The amino terminus of the peptide is always in the bottom (top).

Figure 5. Pa-MAP molecular dynamics simulations.

Simulations analysis of conformational stability were performed in water (upper panels) and 50% aqueous TFE (down panels) solution. Physical-chemical parameters such as radius of gyration (Rg) (A and D), root mean square deviation (RMSD) (B and E) and accessibility area for solvent (Area) (C and F) are plotted during 50 ns of simulation.


The emerging incidence of antimicrobial resistance mechanisms developed by microbial pathogens is currently a serious worldwide threat to public health. It is particularly dangerous for immune-compromised patients, and those undergoing anticancer chemotherapy or therapy after organ transplants [41]. Opportunistic pathogens such as bacteria, viruses and fungi can invade various tissues and cause systemic infections, which are considered life-threatening to the patient [42]. In addition, the infectious diseases caused by antibiotic-resistant microorganisms have contributed to making the situation worse, especially for those patients whose treatment with currently available drugs has become less efficient [43], [44].

Due to all these facts, peptides with multiple activities have been extremely attractive for their efficient control of natural resistance episodes in microorganisms, mainly because they show low toxic effects on mammalian cells [45]. These molecules can be obtained from a wide variety of sources, including microorganisms, plants, amphibians, insects, mollusks and fish, presenting a broad range of activity [2]. Here, an alanine-rich peptide was designed from a polar fish, P. americanus, with two repeat antifreeze motifs, as previously reported by Holmberg et al. [14], and clear deleterious activities toward bacteria, fungi, viruses and cancer cells were observed. One of the promiscuous peptide classes is the defensins, which are small, basic and cysteine-rich peptides found in numerous organisms including plants, fungi and humans. Defensins are generally active against a broad spectrum of organisms, such as Gram-positive and Gram-negative bacteria, viruses, fungi and nematodes [46]. Additionally, cyclotides, a family of widely studied plant-derived promiscuous polypeptides also present numerous activities, including antimicrobial, cytotoxic, insecticidal, uterotonic, antiviral, neurotensin antagonism, hemolytic and anthelmintic ones [47]. Recently, a disulphide-free plant peptide from Cocos nucifera, named Cn-AMP1, was characterized as a promiscuous peptide presenting functions that include antibacterial, antifungal, antitumor and immuno-stimulatory activity [48], [49]. Animal peptides such as magainin (Xenopus laevis), mastoporan (Vespa simillima), fowlicidin (Gallus gallus) and LL-37 (Homo sapiens) have also demonstrated multiple functions, including antimicrobial, anticancer, antiviral, insecticidal and hemolytic ones [50][53]. In addition, antimicrobial peptides from teleost fish have been linked to multifunctional activities. Among them can be cited pardaxin (Pardachirus marmoratus), hepcidin (Oreochromis mossambicus), epinecidin (Epinephelus coioides), piscidin (Morone chrysops), misgurin (Misgurnus anguillicaudatus), NRC peptides (Pleuronectes americanus), myxinidin (Myxine glutinosa) and CodCath (Gadus morhua) [53][60].

Firstly, to demonstrate the varied effects of the studied peptide, Pa-MAP was assayed against multiple infectious pathogens. Most bactericidal activities have been related to cationic residues in the literature [9], [61]. Despite the fact that arginine and lysine cationic residues seem to have an important role for antimicrobial activity, Pa-MAP is devoid of these residues, presenting mostly hydrophobic amino acid residues with one histidine and one aspartic acid residue located in the N-termini region. To probe if the side chain of this His1 residue could be protonated at pH 7.0, the pH at which antimicrobial assays were performed, its pKa value was determined by potentiometric titration and was shown to be 6.0, in accordance with the value expected for the free amino acid or for histidine side chains exposed to water. This indicates that antimicrobial activity could be driven mostly by hydrophobic interactions (Figure S1). Furthermore, Pa-MAP showed a higher activity toward Gram-negative (MIC = 30 µM) bacteria when compared to Gram-positive (MIC >115 µM) pathogens.

Pa-MAP also showed deleterious activity against mycelium and yeast fungi belonging to Ascomycota phylum. With this amidated peptide, the polar amino acid residues Thr2, Ser4, Asp5, Thr13, Asn16 and Ser24 create a polar environment for peptide interaction, despite a possible eletrostatic repulsion caused by Asp5 residue. Similar compositions were observed in an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation [62]. In addition, our results were similar to those found for antifungal peptides deposited in APD, which demonstrated a GRAVY index range of −0.900 to 1.505 [63], [64] reinforcing the idea that hydrophobic interactions promoted by the multiple alanine residues and by Met24 are responsible for the second step of interaction with the lipid hydrocarbon backbone.

Pa-MAP also presented antiviral activity. This is possibly due to the presence of hydrophobic amino acid residues, which might interact with the viral envelope and also with phospholipids encountered on the viral surface [65], [66]. Previous descriptions showed various antiviral peptides that presented directly proportional activity in relation to the hydrophobic ratio, suggesting that hydrophobic and aromatic residues are also important for antiviral activity. Lee and coworkers [66] reported that the increase in the hydrophobic ratio for cecropin A-magainin 2 hybrid peptide analogues caused a dramatic increase in virus-cell fusion inhibitory activity against HIV-1 virus. In summary, it seems that different residues might be involved in different functions, especially when the activities against multiple infectious pathogens were evaluated.

Another important concern for peptide pharmacy descriptions consists of evaluating deleterious activities toward mammalian cells. These challenges can be done in two different directions: one against tumor cells to develop anticancer drugs and the other against healthy cells to probe peptide safety. Pa-MAP showed clear activity toward different tumor cell lines in culture. Its antitumor activity, like its antiviral ones, could be related to a higher hydrophobicity ratio (73%) and to the presence of Thr2, Leu12, Thr13 and Met25. These residues were commonly encountered in anticancer peptides, as observed for pardaxin 1, a multifunctional peptide from Pardachirus marmoratus, and in a promiscuous peptide from Epinephelus coioides [67]. Another recent study demonstrated that antitumoral activity improved as hydrophobicity increased for a peptide with a length of 26 residues and an α-helical structure was derived from a small replication protein (RepA) from E. coli [68], [69]. A more detailed analysis of hydropathicity was carried out using the GRAVY index [33], and it was observed that anticancer/antitumor peptides deposited in the antimicrobial database (APD) [70] mostly presented a GRAVY index around −0.823 to 1.3, which corroborates our results, since Pa-MAP presented a GRAVY index of 0.888 [71], [72]. Otherwise, Pa-MAP showed no toxic effects against human erythrocytes, RAW 264.7 and Vero cells at the maximum concentration (115 µM) utilized for all assays (Table 1). A multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch, named BmKbpp, also showed hemolytic activity around 40% at 50 µM [73]. This suggests that Pa-MAP may be a candidate for use as a model for rational design of antibiotic peptides used in the treatment of human diseases caused by pathogenic microorganisms. It seems that the key to toxicity to mammalian cells might be related to membrane composition. Erythrocyte membranes are composed of phospholipids such as phosphatidylcholine (PC) and sphingomyelin (SM) [74], along with the presence of cholesterol. [75] Moreover, the absence of activity toward mammalian cells could be related to the lack of arginines and lysines. For melittin, a promiscuous peptide from Apis mellifera [76], it was demonstrated that mutations of arginine and lysine residues changed the total activity, with a major effect on toxicity to mammalian cells, reducing 8-fold the activity of the peptide after modification [77].

After biochemical characterization Pa-MAP was also analyzed for its biophysical parameters under different conditions. Pa-MAP was analyzed by circular dichroism, molecular modeling and dynamic simulation, showing that in a hydrophilic environment the conformation is dynamically more unstable at the N- and C-terminals. In contrast, the peptide structures were stabilized in all portions in hydrophobic environments. Many NMR studies with antimicrobial peptides demonstrated that a helical structure is favored in micellar media. MSI-594, a magainin variation of an antimicrobial peptide, possesses a parallel orientation in LPS micelles and, interestingly, the conformation in dodecylphosphocholine (DPC) micelles showed a straight ←helix without any long-range packing, as observed in LPS [78]. Studies with temporin analogues, a representative frog-derived AMP and urechistachykinin peptide from the peripheral nervous system of invertebrates such as Urechis unicinctus [79], showed that the native peptides presented α-helical conformation in the SDS environment. The addition of TFE also demonstrated the formation of α-helical structure in a similar manner to that observed in other helical peptides in TFE/water mixtures [80].

In order to determine if hydrophobic interactions contributed to the stability of the Pa-MAP helix, several acetonitrile concentrations (v:v) were assayed. This solvent does not significantly disturb the hydrogen bond stabilizing the helix conformation, as also observed in studies of hydrophobic effects on micelles and biological membrane formation (SDS and TFE solutions). However, some destabilizing effect occurred at high acetonitrile concentrations since the solvent has moderate capability either as hydrogen-bond donor or as hydrogen-bond acceptor [81]. Figure 2C shows that the main effect of acetonitrile was to destabilize the helix above 60% concentration.

Pa-MAP folding in water and TFE was also studied by molecular dynamics using two different initial conformations for the peptide modeled by molecular modeling, thermalized and energy minimization in aqueous phase (A1) and TFE phase (A2). In the A1 phase there is one central helical region in the peptide in which the first three (N-termini), and the last five (C-termini) amino acid residues are nearly unstructured and appear as coils or bends. This extension of the secondary structure is in agreement with the CD data in aqueous solutions. Figure 4A shows the A1 simulation at different moments: one can see that the peptide stabilized at 30 ns and presented N- and C-termini flexibility with around 30% of helical structure unfolding, when comparing the initial (0 ns) and final (50 ns) models in a thermalized system. Stability was also observed through several parameters, including Rg, RMSD and area, and it was demonstrated that in a hydrophilic environment Pa-MAP presents greater instability at the N- and C-terminals. Nevertheless, the conformational predominance was clearly a α-helix whose stability is maintained far from the terminals. Similar results were obtained by Ding and coworkers [82], who evaluated a synthetic alanine-rich peptide, known as AK17, and its analogues AK10G and AK9P, through CD and molecular dynamics. These peptides presented a radius of gyration of 1.05, 0.89 and 0.92 nm, values that are similar to those observed for Pa-MAP at 1.2 nm. The RMSD values obtained for Pa-MAP (0.6 nm) are also in accordance with data obtained in a pure water dynamic simulation for melitin at 0.8 nm [83]. In the A2 phase, Pa-MAP was assayed in the TFE medium, which induces the formation of a α-helical structure also observed for in vitro experiments. Similar data were found for helical synthetic peptides resembling most α-helices found in the native proteins in TFE/water mixtures [80]. Pa-MAP reaches 90% extension in an α-helical conformation in the presence of TFE, being stabilized after 5 ns and remaining so for the 50 ns of simulation. For the A2 system, the obtained result was similar to the results of atomistic simulations in TFE/water mixtures related to C-terminal fragments named Aβ42, obtained from amyloid β-protein (Aβ), a key neurotoxin in Alzheimer’s disease [84], [85]. Similar results were demonstrated by Soufian and coworkers [86], who observed the structural stability of aurein 1.2, an amphipathic peptide with antibacterial and anticancer activity, and its retro analog in TFE/water mixture, where RMSD, Rg and area were evaluated by molecular dynamics.

In summary, the alanine-rich α-helix, together with the hydrophobic Leu12 and Met25 amino acid residues, and the presence of polar and negatively charged residue jointly with amidated C-terminal, convert Pa-MAP into an amphipathic molecule that appears to have the ability to interact in several membrane compositions. Additionally, data reported here suggest that Pa-MAP in a hydrophilic environment possesses unstable N- and C-terminals, which favor anchorage and further interactions with different acid phospholipids, probably mainly at the charged amino group. In the hydrophobic environment of phospholipid membranes, it was hypothesized that the folding of Pa-MAP is guided by hydrophobic interactions to achieve more stable structural conditions. Moreover, this structural flexibility, which allows a switch from helix to coil and vice-versa, according to the medium, enables this peptide to act against different cells, leading us to believe that the multiple actions could be driven by a mixture of composition, three-dimensional structure and solvation.


The understanding of Pa-MAP structural stability and conformational preference at the molecular level in a hydrophobic environment may lead to advances in drug design and therapy. Because of the ever-increasing number of drug-resistant bacteria, healthcare worldwide is facing a serious challenge and there is an urgent need for novel compounds to treat diseases. Host-defense peptides have high potential to become the next generation of bioactive compounds. Understanding the structure-function correlations of these multifunctional peptides could be critical for developing nontoxic therapeutic biotechnological tools. In the literature the majority of reports have demonstrated that antimicrobial activity could be associated with two main physical-chemical parameters: charges and hydrophobicity. This study demonstrated that both properties are important, but are only part of the process. Pa-MAP demonstrated environment-dependent folding according to in vitro and in silico assays, presenting greater conformational stability in hydrophobic media. In summary, deeper understanding of structure-functional relations could help researchers to develop more efficient and safer peptide drugs, with higher affinities against pathogens and cancer cells in comparison to other mammalian cells. Moreover, the understanding of how environmental conditions such as pH, temperature and hydrophobicity can modulate peptide activities due to smooth structural fluctuations could also be important, allowing the development of multidrugs that act at different moments and under varying conditions.

Supporting Information

Figure S1.

Titration curve of Pa-MAP in with sodium hydroxide. Experiment was performed with 0.27 mM of Pa-MAP titrated with 1 mM sodium hydroxide.



The authors wish to thank to Magali Aparecida Rodrigues for help with the potentiometric titration experiment.

Author Contributions

Conceived and designed the experiments: LM ONS BSM OLF. Performed the experiments: LM ONS PAS MPC CRC DON JARGB MRRS MPB LMPL MTVR SMF BSM OLF. Analyzed the data: LM ONS MPB SMF BSM OLF. Contributed reagents/materials/analysis tools: SMF OLF. Wrote the paper: LM ONS BSM JARGB BSM OLF.


  1. 1. Nobeli I, Favia AD, Thornton JM (2009) Protein promiscuity and its implications for biotechnology. Nat Biotechnol 27: 157–167.
  2. 2. Bechinger B (2010) Insights into themechanisms of action of host defence peptides from biophysical and structural investigations. Journal of Peptide Science 17: 306–314.
  3. 3. Kuiper MJ, Fecondo JV, Wong MG (2002) Rational design of α-helical antifreeze peptides. J Pept Res 59: 1–8.
  4. 4. Fletcher GL, Hew CL, Davies PL (2001) Antifreeze proteins of teleost fishes. Annu Rev Physiol 63: 359–390.
  5. 5. Gong Z, Ewart KV, Hu Z, Fletcher GL, Hew CL (1996) Skin antifreeze protein genes of the winter flounder, Pleuronectes americanus, encode distinct and active polypeptides without the secretory signal and prosequences. J Biol Chem 271: 4106–4112.
  6. 6. Hew CL, Joshi S, Wang NC, Kao MH, Ananthanarayanan VS (1985) Structures of shorthorn sculpin antifreeze polypeptides. Eur J Biochem 151: 167–172.
  7. 7. Wang Z, Wang G (2004) APD: the Antimicrobial Peptide Database. Nucleic Acids Res 32: D590–592.
  8. 8. Oren Z, Shai Y (1998) Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47: 451–463.
  9. 9. Franco OL (2011) Peptide promiscuity: an evolutionary concept for plant defense. FEBS Lett 585: 995–1000.
  10. 10. Hincha DK, DeVries AL, Schmitt JM (1993) Cryotoxicity of antifreeze proteins and glycoproteins to spinach thylakoid membranes–comparison with cryotoxic sugar acids. Biochim Biophys Acta 1146: 258–264.
  11. 11. Tomczak MM, Hincha DK, Estrada SD, Wolkers WF, Crowe LM, et al. (2002) A mechanism for stabilization of membranes at low temperatures by an antifreeze protein. Biophys J 82: 874–881.
  12. 12. Kun H, Minnes R, Mastai Y (2008) Effects antifreeze peptides on the thermotropic properties of a model membrane. J Bioenerg Biomembr 40: 389–396.
  13. 13. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551–1557.
  14. 14. Holmberg N, Lilius G, Bulow L (1994) Artificial antifreeze proteins can improve NaCl tolerance when expressed in E. coli. FEBS Lett 349: 354–358.
  15. 15. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2012) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 40: D13–25.
  16. 16. Hall T (1999) BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 4.
  17. 17. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680.
  18. 18. Chan WC, White PD (2000) Fmoc Solid Phase Peptide Synthesis: A Practical Approach; Hames BD, editor.
  19. 19. Murphy J, Kies M (1960) Note on the spectrophotometric determination of proteins in dilute solutions. Biochimica et Biophysica Acta 3: 382–384.
  20. 20. Crouch SR, Skoog DA, West DM, Holler FJ (2004) Fundamentals of Analytical Chemistry with Infotrac.
  21. 21. Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24: 119–124.
  22. 22. Wikler M, Cockerill F, Bush K, Dudley M, Eliopoulos G, et al.. (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: Clinical and Laboratory Standards Institute. 10 p.
  23. 23. Markoulatos P, Georgopoulou A, Siafakas N, Plakokefalos E, Tzanakaki G, et al. (2001) Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay. J Clin Microbiol 39: 4426–4432.
  24. 24. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. The American Journal of Hygiene 27: 5.
  25. 25. Simões C, Castro T, Cordeiro L, Albarello N, Mansur E, et al. (2010) Antiviral activity of Cleome rosea extracts from field-grown plants and tissue culture-derived materials against acyclovir-resistant Herpes simplex viruses type 1 (ACVr-HSV-1) and type 2 (ACVr-HSV-2). World Journal Microbiology Biotechnology 26: 93–99.
  26. 26. Nishimura T, Toku H, Fukuyasu H (1977) Antiviral compounds. XII. Antiviral activity of amidinohydrazones of alkoxyphenyl-substituted carbonyl compounds against influenza virus in eggs and in mice. Kitasato Arch Exp Med 50: 39–46.
  27. 27. Morrisett JD, David JS, Pownall HJ, Gotto AM Jr (1973) Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry 12: 1290–1299.
  28. 28. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al.. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5 6.
  29. 29. Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35: W407–410.
  30. 30. Sumathi K, Ananthalakshmi P, Roshan MN, Sekar K (2006) 3dSS: 3D structural superposition. Nucleic Acids Res 34: W128–132.
  31. 31. DeLano W (2002) The PyMOL molecular graphics system.
  32. 32. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson–Boltzmann electrostatics calculations. Nucleic Acids Research 32: W665–W667.
  33. 33. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, et al. (1999) Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 112: 531–552.
  34. 34. Lindahl E, Hess B, van der Spoel D (2001) GROMACS 3.0: a package for molecular simulation and trajectory analysis. Journal of Molecular Modeling 7: 306–317.
  35. 35. Berendsen H, Postma J, van Gunsteren W, Hermans J (1981) Interaction models for water in relation to protein hydration. In Intermolecular Force Reidel, Dordrecht 12: 331–342.
  36. 36. Miyamoto S, Kollman P (1992) SETTLE: an analytical version of the SHAKE and RATTLE algorithms for rigid water models. Journal of Computational Chemistry 13: 952–962.
  37. 37. Hess B, Bekker H, Berendsen H, Fraaije J (1997) LINCS: a linear constraint solver for molecular simulations. Journal of Computational Chemistry 18: 1463–1472.
  38. 38. Liepinsh E, Otting G, Harding MM, Ward LG, Mackay JP, et al. (2002) Solution structure of a hydrophobic analogue of the winter flounder antifreeze protein. Eur J Biochem 269: 1259–1266.
  39. 39. Rost B, Yachdav G, Liu J (2004) The PredictProtein server. Nucleic Acids Res 32: W321–326.
  40. 40. Geourjon C, Deleage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 11: 681–684.
  41. 41. Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A (2010) Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transplant 8: 146–149.
  42. 42. Cutler DM (2007) The lifetime costs and benefits of medical technology. J Health Econ 26: 1081–1100.
  43. 43. Foubister V (2003) New mode of intervention in sepsis treatment. Drug Discov Today 8: 610–612.
  44. 44. Carrillo-Munoz AJ, Giusiano G, Ezkurra PA, Quindos G (2006) Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter 19: 130–139.
  45. 45. Hilpert K, Volkmer-Engert R, Walter T, Hancock RE (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol 23: 1008–1012.
  46. 46. Pelegrini PB, Franco OL (2005) Plant gamma-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteins. Int J Biochem Cell Biol 37: 2239–2253.
  47. 47. Pinto MF, Fensterseifer IC, Migliolo L, Sousa DA, de Capdville G, et al. (2012) Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane. J Biol Chem 287: 134–147.
  48. 48. Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, et al. (2009) Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water. Peptides 30: 633–637.
  49. 49. Silva ON, Porto WF, Migliolo L, Mandal SM, Garcês DG, et al.. (2012) CnAMP-1: a new promiscuous peptide with potential for microbial infections treatment. Biopolymers Journal In press.
  50. 50. Zasloff M, Martin B, Chen HC (1988) Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A 85: 910–913.
  51. 51. Yi N, Li N (2010) Transient expression of chicken antimicrobial peptides by mouse mammary carcinoma cells C127. Protein Pept Lett 17: 1517–1523.
  52. 52. Baek JH, Ji Y, Shin JS, Lee S, Lee SH (2011) Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Peptides 32: 568–572.
  53. 53. Lee CC, Sun Y, Qian S, Huang HW (2011) Transmembrane pores formed by human antimicrobial peptide LL-37. Biophys J 100: 1688–1696.
  54. 54. Vad BS, Bertelsen K, Johansen CH, Pedersen JM, Skrydstrup T, et al. (2010) Pardaxin permeabilizes vesicles more efficiently by pore formation than by disruption. Biophys J 98: 576–585.
  55. 55. Chang WT, Pan CY, Rajanbabu V, Cheng CW, Chen JY (2011) Tilapia (Oreochromis mossambicus) antimicrobial peptide, hepcidin 1–5, shows antitumor activity in cancer cells. Peptides 32: 342–352.
  56. 56. Park NG, Silphaduang U, Moon HS, Seo JK, Corrales J, et al. (2011) Structure-activity relationships of piscidin 4, a piscine antimicrobial peptide. Biochemistry 50: 3288–3299.
  57. 57. Park CB, Lee JH, Park IY, Kim MS, Kim SC (1997) A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus. FEBS Lett 411: 173–178.
  58. 58. Douglas SE, Gallant JW, Liebscher RS, Dacanay A, Tsoi SC (2003) Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Dev Comp Immunol 27: 589–601.
  59. 59. Subramanian S, Ross NW, MacKinnon SL (2009) Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar Biotechnol (NY). 11: 748–757.
  60. 60. Broekman DC, Zenz A, Gudmundsdottir BK, Lohner K, Maier VH, et al. (2011) Functional characterization of codCath, the mature cathelicidin antimicrobial peptide from Atlantic cod (Gadus morhua). Peptides 32: 2044–2051.
  61. 61. Mandal SM, Migliolo L, Das S, Mandal M, Franco OL, et al. (2012) Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties. J Cell Biochem 113: 184–193.
  62. 62. Mandal SM, Migliolo L, Franco OL, Ghosh AK (2011) Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation. Peptides 32: 1741–1747.
  63. 63. Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, et al. (1996) Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci U S A 93: 1221–1225.
  64. 64. Lee WH, Li Y, Lai R, Li S, Zhang Y, et al. (2005) Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification. Eur J Immunol 35: 1220–1229.
  65. 65. Chang SL, Griesgraber G, Wagner CR (2001) Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT). Nucleosides Nucleotides Nucleic Acids 20: 1571–1582.
  66. 66. Lee DG, Park Y, Jin I, Hahm KS, Lee HH, et al. (2004) Structure-antiviral activity relationships of cecropin A-magainin 2 hybrid peptide and its analogues. J Pept Sci 10: 298–303.
  67. 67. Pan CY, Chen JY, Cheng YS, Chen CY, Ni IH, et al. (2007) Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection. DNA Cell Biol 26: 403–413.
  68. 68. Zhang L, Falla T, Wu M, Fidai S, Burian J, et al. (1998) Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem Biophys Res Commun 247: 674–680.
  69. 69. Huang YB, Wang XF, Wang HY, Liu Y, Chen Y (2012) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol Cancer Ther 10: 416–426.
  70. 70. Wang G, Li X, Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933–937.
  71. 71. Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, et al. (2000) The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur J Biochem 267: 5330–5341.
  72. 72. Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, et al. (2002) Antiviral and antitumor peptides from insects. Proc Natl Acad Sci U S A 99: 12628–12632.
  73. 73. Zeng XC, Wang S, Nie Y, Zhang L, Luo X (2011) Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: Gaining insight into a new mechanism for the functional diversification of scorpion venom peptides. Peptides 33: 44–51.
  74. 74. Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, et al. (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 323: 178–193.
  75. 75. Turner JD, Rouser G (1970) Precise quantitative determination of human blood lipids by thin-layer and triethylaminoethylcellulose column chromatography. I. Erythrocyte lipids. Anal Biochem 38: 423–436.
  76. 76. Kreil G (1973) Biosynthesis of melittin, a toxic peptide from bee venom. Amino-acid sequence of the precursor. Eur J Biochem 33: 558–566.
  77. 77. Werkmeister JA, Kirkpatrick A, McKenzie JA, Rivett DE (1993) The effect of sequence variations and structure on the cytolytic activity of melittin peptides. Biochim Biophys Acta 1157: 50–54.
  78. 78. Domadia PN, Bhunia A, Ramamoorthy A, Bhattacharjya S (2011) Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization. J Am Chem Soc 132: 18417–18428.
  79. 79. Sung WS, Park SH, Lee DG (2008) Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus. FEBS Lett 582: 2463–2466.
  80. 80. Jasanoff A, Fersht AR (1994) Quantitative determination of helical propensities from trifluoroethanol titration curves. Biochemistry 33: 2129–2135.
  81. 81. Kamlet MJ, Abboud JLM, Abraham MH, Taft RW (1983) Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters, pi-star, α and β, and some methods for simplifying the generalized solvatochromic equation. J Org Chem 48: 2877–2887.
  82. 82. Ding T, Li R, Zeitler JA, Huber TL, Gladden LF, et al. (2010) Terahertz and far infrared spectroscopy of alanine-rich peptides having variable ellipticity. Opt Express 18: 27431–27444.
  83. 83. Roccatano D, Colombo G, Fioroni M, Mark AE (2002) Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study. Proc Natl Acad Sci U S A 99: 12179–12184.
  84. 84. Jalili S, Akhavan M (2010) Molecular dynamics simulation study of association in trifluoroethanol/water mixtures. J Comput Chem 31: 286–294.
  85. 85. Li H, Monien BH, Fradinger EA, Urbanc B, Bitan G (2010) Biophysical characterization of Aβ42 C-terminal fragments: inhibitors of Aβ42 neurotoxicity. Biochemistry 49: 1259–1267.
  86. 86. Soufian S, Naderi-Manesh H, Alizadeh A, Sarbolouki M (2009) Molecular Dynamics and circular dichroism studies on Aurein 1.2 and retro analog. World Acad Sci Eng Tech 56: 858–864.